Emerging Treatment Approaches in COPD

Author(s):

Fernando J. Martinez, MD, MS,Nicola Hanania, MD, MS

The panel discusses emerging treatment approaches in COPD and reviews the study design and topline results from the BOREAS trial investigating dupilumab.

EP: 1.Why is COPD Important?

EP: 2.COPD Traits Associated with Phenotypes

EP: 3.Insights Gleaned from Asthma Research for COPD

EP: 4.Biomarkers in COPD

EP: 5.Unmet Needs in the COPD Treatment Landscape

EP: 6.The Role of Eosinophils in Diagnosing COPD

EP: 7.GOLD Treatment Guidelines and Evolving Therapeutic Approaches

EP: 8.Evolving Treatment Landscape in COPD

Now Viewing

EP: 9.Emerging Treatment Approaches in COPD

EP: 10.Future Treatment Landscape for COPD

EP: 11.The Benefits of Earlier Diagnosis and Treatment of COPD

EP: 12.The Relationship Between Comorbidities in COPD

EP: 13.The Role of Primary Care Providers in Managing Patients with COPD

EP: 14.Key Takeaways on the Evolving COPD Treatment Landscape

Can you discuss the emerging treatment approaches in COPD?
1. The Interleukin-4/Interleukin-13 Receptor
2. IL-33 Signaling
3. ST-2 (IL-33R)
We have recently received data form the BOREAS trial on dupilumab in COPD. Can you discuss the design and topline results? Bhatt et al 2023
1. Phase 3 NOTUS study?